Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva MA, Drago F.

Pharmacol Rev. 2018 Jul;70(3):475-504. doi: 10.1124/pr.117.014977.

PMID:
29884653
2.

Non-toxic engineered carbon nanodiamond concentrations induce oxidative/nitrosative stress, imbalance of energy metabolism, and mitochondrial dysfunction in microglial and alveolar basal epithelial cells.

Fresta CG, Chakraborty A, Wijesinghe MB, Amorini AM, Lazzarino G, Lazzarino G, Tavazzi B, Lunte SM, Caraci F, Dhar P, Caruso G.

Cell Death Dis. 2018 Feb 14;9(2):245. doi: 10.1038/s41419-018-0280-z.

3.

Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target.

Caraci F, Spampinato SF, Morgese MG, Tascedda F, Salluzzo MG, Giambirtone MC, Caruso G, Munafò A, Torrisi SA, Leggio GM, Trabace L, Nicoletti F, Drago F, Sortino MA, Copani A.

Pharmacol Res. 2018 Apr;130:374-384. doi: 10.1016/j.phrs.2018.02.007. Epub 2018 Feb 10. Review.

PMID:
29438781
4.

Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease.

Caraci F, Nicoletti F, Copani A.

Curr Opin Pharmacol. 2018 Feb;38:1-7. doi: 10.1016/j.coph.2017.12.001. Epub 2017 Dec 23. Review.

PMID:
29278824
5.

Preface Drug discovery in neurodegenerative disorders: a defeat for pharmacology?

Caraci F, Kraneveld A, Krzan M, Luca MD.

Eur J Pharmacol. 2017 Dec 15;817:1. doi: 10.1016/j.ejphar.2017.11.014. No abstract available.

PMID:
29162230
6.

Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.

Di Menna L, Joffe ME, Iacovelli L, Orlando R, Lindsley CW, Mairesse J, Gressèns P, Cannella M, Caraci F, Copani A, Bruno V, Battaglia G, Conn PJ, Nicoletti F.

Neuropharmacology. 2018 Jan;128:301-313. doi: 10.1016/j.neuropharm.2017.10.026. Epub 2017 Oct 25.

PMID:
29079293
7.

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade.

Torrisi SA, Salomone S, Geraci F, Caraci F, Bucolo C, Drago F, Leggio GM.

Front Pharmacol. 2017 Oct 4;8:710. doi: 10.3389/fphar.2017.00710. eCollection 2017.

8.

Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.

Caraci F, Iulita MF, Pentz R, Flores Aguilar L, Orciani C, Barone C, Romano C, Drago F, Cuello AC.

Eur J Pharmacol. 2017 Dec 15;817:7-19. doi: 10.1016/j.ejphar.2017.10.004. Epub 2017 Oct 5. Review.

PMID:
28987272
9.

Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases.

Platania CBM, Fisichella V, Fidilio A, Geraci F, Lazzara F, Leggio GM, Salomone S, Drago F, Pignatello R, Caraci F, Bucolo C.

Int J Mol Sci. 2017 Sep 30;18(10). pii: E2076. doi: 10.3390/ijms18102076.

10.

New drugs in psychiatry: focus on new pharmacological targets.

Caraci F, Leggio GM, Salomone S, Drago F.

F1000Res. 2017 Mar 30;6:397. doi: 10.12688/f1000research.10233.1. eCollection 2017. Review.

11.

A new nomenclature for classifying psychotropic drugs.

Caraci F, Enna SJ, Zohar J, Racagni G, Zalsman G, van den Brink W, Kasper S, Koob GF, Pariante CM, Piazza PV, Yamada K, Spedding M, Drago F.

Br J Clin Pharmacol. 2017 Aug;83(8):1614-1616. doi: 10.1111/bcp.13302. Epub 2017 May 24.

12.

Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs.

Caraci F, Sultana J, Drago F, Spina E.

CNS Neurol Disord Drug Targets. 2017;16(4):501-513. doi: 10.2174/1871527316666170303144817. Review.

PMID:
28260511
13.

Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer's Disease.

Simoni E, Caporaso R, Bergamini C, Fiori J, Fato R, Miszta P, Filipek S, Caraci F, Giuffrida ML, Andrisano V, Minarini A, Bartolini M, Rosini M.

ACS Med Chem Lett. 2016 Sep 26;7(12):1145-1150. eCollection 2016 Dec 8.

14.

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.

Malaguarnera G, Bertino G, Chisari G, Motta M, Vecchio M, Vacante M, Caraci F, Greco C, Drago F, Nunnari G, Malaguarnera M.

BMC Psychiatry. 2016 Nov 15;16(1):398.

15.

Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1.

Caraci F, Tascedda F, Merlo S, Benatti C, Spampinato SF, Munafò A, Leggio GM, Nicoletti F, Brunello N, Drago F, Sortino MA, Copani A.

Front Pharmacol. 2016 Oct 25;7:389. eCollection 2016.

16.

Corrigendum: Ac-LPFFD-Th: A Trehalose-Conjugated Peptidomimetic as a Strong Suppressor of Amyloid-β Oligomer Formation and Cytotoxicity.

Sinopoli A, Giuffrida A, Tomasello MF, Giuffrida ML, Leone M, Attanasio F, Caraci F, De Bona P, Naletova I, Saviano M, Copani A, Pappalardo G, Rizzarelli E.

Chembiochem. 2016 Oct 17;17(20):1993. doi: 10.1002/cbic.201600502. Epub 2016 Sep 23. No abstract available.

PMID:
27758068
17.

Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas.

Praticò AD, Caraci F, Pavone P, Falsaperla R, Drago F, Ruggieri M.

Drug Saf Case Rep. 2015 Dec;2(1):6.

18.

Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.

Castellano S, Ventimiglia A, Salomone S, Ventimiglia A, De Vivo S, Signorelli MS, Bellelli E, Santagati M, Cantarella RA, Fazio E, Aguglia E, Drago F, Di Nuovo S, Caraci F.

CNS Neurol Disord Drug Targets. 2016;15(10):1290-1298.

PMID:
27712575
19.

An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation.

Iulita MF, Ower A, Barone C, Pentz R, Gubert P, Romano C, Cantarella RA, Elia F, Buono S, Recupero M, Romano C, Castellano S, Bosco P, Di Nuovo S, Drago F, Caraci F, Cuello AC.

Alzheimers Dement. 2016 Nov;12(11):1132-1148. doi: 10.1016/j.jalz.2016.05.001. Epub 2016 Jul 21.

PMID:
27452424
20.

Ac-LPFFD-Th: A Trehalose-Conjugated Peptidomimetic as a Strong Suppressor of Amyloid-β Oligomer Formation and Cytotoxicity.

Sinopoli A, Giuffrida A, Tomasello MF, Giuffrida ML, Leone M, Attanasio F, Caraci F, De Bona P, Naletova I, Saviano M, Copani A, Pappalardo G, Rizzarelli E.

Chembiochem. 2016 Aug 17;17(16):1541-9. doi: 10.1002/cbic.201600243. Epub 2016 Jul 7. Erratum in: Chembiochem. 2016 Oct 17;17 (20):1993.

PMID:
27252026
21.

The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders.

Bruno V, Caraci F, Copani A, Matrisciano F, Nicoletti F, Battaglia G.

Neuropharmacology. 2017 Mar 15;115:180-192. doi: 10.1016/j.neuropharm.2016.04.044. Epub 2016 Apr 30. Review.

PMID:
27140693
22.

Editorial: Linkage of CNS and Immunology with Psychology: Searching for New Pharmacological Targets.

Caraci F, Kamal MA.

CNS Neurol Disord Drug Targets. 2016;15(4):378-80. No abstract available.

PMID:
27040760
23.

A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome.

Iulita MF, Caraci F, Cuello AC.

CNS Neurol Disord Drug Targets. 2016;15(4):434-47. Review.

PMID:
26996175
24.

The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice.

Leggio GM, Catania MV, Puzzo D, Spatuzza M, Pellitteri R, Gulisano W, Torrisi SA, Giurdanella G, Piazza C, Impellizzeri AR, Gozzo L, Navarria A, Bucolo C, Nicoletti F, Palmeri A, Salomone S, Copani A, Caraci F, Drago F.

Pharmacol Res. 2016 Apr;106:10-20. doi: 10.1016/j.phrs.2016.02.007. Epub 2016 Feb 10.

PMID:
26875816
25.

TGF-β1 prevents rat retinal insult induced by amyloid-β (1-42) oligomers.

Fisichella V, Giurdanella G, Platania CB, Romano GL, Leggio GM, Salomone S, Drago F, Caraci F, Bucolo C.

Eur J Pharmacol. 2016 Sep 15;787:72-7. doi: 10.1016/j.ejphar.2016.02.002. Epub 2016 Feb 2.

PMID:
26845696
26.

Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.

Malaguarnera M, Motta M, Vacante M, Malaguarnera G, Caraci F, Nunnari G, Gagliano C, Greco C, Chisari G, Drago F, Bertino G.

Am J Transl Res. 2015 Nov 15;7(11):2510-8. eCollection 2015.

27.

Cognitive Symptoms In Major Depressive Disorder And Their Italian Psychiatrists' Perception.

Pegoraro V, Cataldo N, Albert U, Brugnoli R, Caraci F, Dell'Osso BM, Di Sciascio G, Tortorella A, Vampini C.

Value Health. 2015 Nov;18(7):A406-7. doi: 10.1016/j.jval.2015.09.956. Epub 2015 Oct 20. No abstract available.

28.

Italian psychiatrists' perception on cognitive symptoms in major depressive disorder.

Albert U, Brugnoli R, Caraci F, Dell'Osso B, Di Sciascio G, Tortorella A, Vampini C, Cataldo N, Pegoraro V.

Int J Psychiatry Clin Pract. 2016;20(1):2-9. doi: 10.3109/13651501.2015.1093147. Epub 2015 Nov 2.

PMID:
26523906
29.

Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons.

Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A.

Front Cell Neurosci. 2015 Aug 7;9:297. doi: 10.3389/fncel.2015.00297. eCollection 2015.

30.

Folate status in type 2 diabetic patients with and without retinopathy.

Malaguarnera G, Gagliano C, Salomone S, Giordano M, Bucolo C, Pappalardo A, Drago F, Caraci F, Avitabile T, Motta M.

Clin Ophthalmol. 2015 Aug 7;9:1437-42. doi: 10.2147/OPTH.S77538. eCollection 2015.

31.

Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity.

Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S.

Eur J Pharmacol. 2015 Oct 5;764:256-63. doi: 10.1016/j.ejphar.2015.07.015. Epub 2015 Jul 7.

PMID:
26162702
32.

Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow.

Devroye C, Cathala A, Di Marco B, Caraci F, Drago F, Piazza PV, Spampinato U.

Neuropharmacology. 2015 Oct;97:329-37. doi: 10.1016/j.neuropharm.2015.06.012. Epub 2015 Jun 25.

PMID:
26116760
33.

A key role for TGF-β1 in hippocampal synaptic plasticity and memory.

Caraci F, Gulisano W, Guida CA, Impellizzeri AA, Drago F, Puzzo D, Palmeri A.

Sci Rep. 2015 Jun 10;5:11252. doi: 10.1038/srep11252.

34.

Does Mood Disorder Questionnaire identify sub-threshold bipolarity? Evidence studying worsening of quality of life.

Carta MG, Norcini-Pala A, Moro MF, Balestrieri M, Caraci F, Dell'Osso L, Sciascio GD, Faravelli C, Hardoy MC, Aguglia E, Roncone R, Nardi AE, Drago F.

J Affect Disord. 2015 Sep 1;183:173-8. doi: 10.1016/j.jad.2015.04.058. Epub 2015 May 11.

PMID:
26021966
35.

The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.

Carta MG, Moro MF, Aguglia E, Balestrieri M, Caraci F, Dell'Osso L, Di Sciascio G, Drago F, Hardoy MC, D'Aloja E, Machado S, Roncone R, Faravelli C.

Int J Soc Psychiatry. 2015 Nov;61(7):693-9. doi: 10.1177/0020764015573848. Epub 2015 Mar 12.

PMID:
25770204
36.

Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam.

Leggio GM, Torrisi SA, Castorina A, Platania CB, Impellizzeri AA, Fidilio A, Caraci F, Bucolo C, Drago F, Salomone S.

Eur Neuropsychopharmacol. 2015 Sep;25(9):1427-36. doi: 10.1016/j.euroneuro.2014.11.004. Epub 2014 Nov 15.

PMID:
25482686
37.

Eating disorders as a public health issue: prevalence and attributable impairment of quality of life in an Italian community sample.

Carta MG, Preti A, Moro MF, Aguglia E, Balestrieri M, Caraci F, Dell'Osso L, Di Sciascio G, Drago F, Faravelli C, Hardoy MC, D'Aloja E, Cossu G, Calò S, Palumbo G, Bhugra D.

Int Rev Psychiatry. 2014 Aug;26(4):486-92. doi: 10.3109/09540261.2014.927753.

PMID:
25137115
38.

Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.

Orlando R, Borro M, Motolese M, Molinaro G, Scaccianoce S, Caruso A, di Nuzzo L, Caraci F, Matrisciano F, Pittaluga A, Mairesse J, Simmaco M, Nisticò R, Monn JA, Nicoletti F.

Neuropharmacology. 2014 Nov;86:133-44. doi: 10.1016/j.neuropharm.2014.07.009. Epub 2014 Jul 22.

PMID:
25063582
39.

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.

Malaguarnera G, Pennisi M, Gagliano C, Vacante M, Malaguarnera M, Salomone S, Drago F, Bertino G, Caraci F, Nunnari G, Malaguarnera M.

Hepat Mon. 2014 May 5;14(5):e11608. doi: 10.5812/hepatmon.11608. eCollection 2014 May.

40.

Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy.

Malaguarnera G, Gagliano C, Giordano M, Salomone S, Vacante M, Bucolo C, Caraci F, Reibaldi M, Drago F, Avitabile T, Motta M.

Biomed Res Int. 2014;2014:191497. doi: 10.1155/2014/191497. Epub 2014 Apr 28.

41.

Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.

Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F.

PLoS One. 2014 May 7;9(5):e96905. doi: 10.1371/journal.pone.0096905. eCollection 2014.

42.

Omega-3 fatty acids and depression: scientific evidence and biological mechanisms.

Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, Caraci F.

Oxid Med Cell Longev. 2014;2014:313570. doi: 10.1155/2014/313570. Epub 2014 Mar 18. Review.

43.

Comparing factor structure of the Mood Disorder Questionnaire (MDQ): In Italy sexual behavior is euphoric but in Asia mysterious and forbidden.

Carta MG, Massidda D, Moro MF, Aguglia E, Balestrieri M, Caraci F, Dell'Osso L, Di Sciascio G, Drago F, Faravelli C, Hardoy MC, Calò S, Pollice R, Fortezzo A, Akiskal H.

J Affect Disord. 2014 Feb;155:96-103. doi: 10.1016/j.jad.2013.10.030. Epub 2013 Oct 31.

PMID:
24238869
44.

Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment.

Bosco P, Ferri R, Salluzzo MG, Castellano S, Signorelli M, Nicoletti F, Nuovo SD, Drago F, Caraci F.

Curr Genomics. 2013 Apr;14(2):147-56. doi: 10.2174/1389202911314020007.

45.

Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?

Caraci F, Castellano S, Salomone S, Drago F, Bosco P, Di Nuovo S.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):173-86. Review.

PMID:
24040795
46.

Pericentrin expression in Down's syndrome.

Salemi M, Barone C, Romano C, Salluzzo R, Caraci F, Cantarella RA, Salluzzo MG, Drago F, Romano C, Bosco P.

Neurol Sci. 2013 Nov;34(11):2023-5. doi: 10.1007/s10072-013-1529-z. Epub 2013 Aug 27.

PMID:
23979692
47.

Clinical pharmacology of novel anti-Alzheimer disease modifying medications.

Caraci F, Bosco P, Leggio GM, Malaguarnera M, Drago F, Bucolo C, Salomone S.

Curr Top Med Chem. 2013;13(15):1853-63. Review.

PMID:
23931438
48.

Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.

Leggio GM, Salomone S, Bucolo C, Platania C, Micale V, Caraci F, Drago F.

Eur J Pharmacol. 2013 Nov 5;719(1-3):25-33. doi: 10.1016/j.ejphar.2013.07.022. Epub 2013 Jul 18. Review.

PMID:
23872400
49.

Metal fume fever.

Malaguarnera M, Drago F, Malaguarnera G, Li Volti G, Salomone S, Caraci F, Galvano F, Vacante M, Bucolo C, Malaguarnera M.

Lancet. 2013 Jun 29;381(9885):2298. doi: 10.1016/S0140-6736(13)60689-3. No abstract available.

PMID:
23809563
50.

New definition of addiction proposed by the American Society of Addiction Medicine: which implications for the treatment of tobacco dependence?

Caraci F, Drago F.

Eur Neuropsychopharmacol. 2014 Jan;24(1):1-4. doi: 10.1016/j.euroneuro.2013.05.003. Epub 2013 Jun 16. No abstract available.

PMID:
23778079

Supplemental Content

Loading ...
Support Center